METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS
This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl 2 anti apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ELMORE, Steven SOUERS, Andrew PERPER, Stuart J GHAYUR, Tariq WANG, Li Chun |
| description | This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl 2 anti apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl- xL. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PH12016500939B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PH12016500939B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PH12016500939B13</originalsourceid><addsrcrecordid>eNrjZDD1dQ3x8HcJVvB3UwgJcnUM8XX1C1EIDfb0c1cIdvVxdQ7xDHNVcHL20TVS8PTz8HTyDPEPCuZhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfEBHoZGBoZmpgYGlsaWTobGRCoDAM86KM4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS</title><source>esp@cenet</source><creator>ELMORE, Steven ; SOUERS, Andrew ; PERPER, Stuart J ; GHAYUR, Tariq ; WANG, Li Chun</creator><creatorcontrib>ELMORE, Steven ; SOUERS, Andrew ; PERPER, Stuart J ; GHAYUR, Tariq ; WANG, Li Chun</creatorcontrib><description>This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl 2 anti apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl- xL.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170614&DB=EPODOC&CC=PH&NR=12016500939B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170614&DB=EPODOC&CC=PH&NR=12016500939B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ELMORE, Steven</creatorcontrib><creatorcontrib>SOUERS, Andrew</creatorcontrib><creatorcontrib>PERPER, Stuart J</creatorcontrib><creatorcontrib>GHAYUR, Tariq</creatorcontrib><creatorcontrib>WANG, Li Chun</creatorcontrib><title>METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS</title><description>This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl 2 anti apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl- xL.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD1dQ3x8HcJVvB3UwgJcnUM8XX1C1EIDfb0c1cIdvVxdQ7xDHNVcHL20TVS8PTz8HTyDPEPCuZhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfEBHoZGBoZmpgYGlsaWTobGRCoDAM86KM4</recordid><startdate>20170614</startdate><enddate>20170614</enddate><creator>ELMORE, Steven</creator><creator>SOUERS, Andrew</creator><creator>PERPER, Stuart J</creator><creator>GHAYUR, Tariq</creator><creator>WANG, Li Chun</creator><scope>EVB</scope></search><sort><creationdate>20170614</creationdate><title>METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS</title><author>ELMORE, Steven ; SOUERS, Andrew ; PERPER, Stuart J ; GHAYUR, Tariq ; WANG, Li Chun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PH12016500939B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ELMORE, Steven</creatorcontrib><creatorcontrib>SOUERS, Andrew</creatorcontrib><creatorcontrib>PERPER, Stuart J</creatorcontrib><creatorcontrib>GHAYUR, Tariq</creatorcontrib><creatorcontrib>WANG, Li Chun</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ELMORE, Steven</au><au>SOUERS, Andrew</au><au>PERPER, Stuart J</au><au>GHAYUR, Tariq</au><au>WANG, Li Chun</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS</title><date>2017-06-14</date><risdate>2017</risdate><abstract>This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl 2 anti apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl- xL.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_PH12016500939B1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A03%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ELMORE,%20Steven&rft.date=2017-06-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPH12016500939B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |